-
QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications
30 May 2024 21:55 GMT
… by AstraZeneca. “Our partnership with Myriad Genetics underscores a shared commitment to … s oncology products portfolio. About Myriad Genetics Myriad Genetics is a leading genetic testing … net sales and adjusted diluted earnings results, are forward-looking, …
-
QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications
30 May 2024 20:05 GMT
… by AstraZeneca. “Our partnership with Myriad Genetics underscores a shared commitment to … s oncology products portfolio. About Myriad Genetics Myriad Genetics is a leading genetic testing … net sales and adjusted diluted earnings results, are forward-looking, …
-
Myriad Genetics, Inc. (NASDAQ:MYGN) Q1 2024 Earnings Call Transcript
08 May 2024 21:17 GMT
Myriad Genetics, Inc. (NASDAQ:MYGN) Q1 2024 Earnings Call Transcript May 7, 2024
Myriad Genetics, … by, and welcome to Myriad Genetics First Quarter 2024 Earnings Conference Call. At … welcome to the Myriad Genetics first quarter 2024 earnings call. During the …
-
Myriad Genetics Inc. Q1 Loss Decreases, beats estimates
07 May 2024 20:59 GMT
Myriad Genetics Inc. (MYGN) reported Loss for … quarter.
Excluding items, Myriad Genetics Inc. reported adjusted earnings of -$0.5 million … million last year.
Myriad Genetics Inc. earnings at a glance (GAAP) :
-Earnings (Q1): -$26 …
-
Myriad Genetics Reports Strong First Quarter 2024 Financial Results; Achieves 12% Revenue Growth Year-Over-Year; Significantly Improved Year-Over-Year Net Loss and Generated Positive Adjusted EBITDA
07 May 2024 20:05 GMT
… quarter GAAP earnings per share and adjusted earnings per share … .myriad.com. About Myriad Genetics
Myriad Genetics is a leading genetic …
(1) To determine Adjusted Earnings (Loss) Per Share, or … historical and forecasted positive earnings performance.
As of …
-
Myriad Genetics Q1 24 Earnings Conference Call At 4:30 PM ET
07 May 2024 20:14 GMT
Myriad Genetics Inc. () will host a conference … , 2024, to discuss Q1 24 earnings results.
To access the live …
-
Myriad Genetics to Release First Quarter 2024 Financial Results on May 7, 2024
30 Apr 2024 20:05 GMT
… will hold its first quarter earnings conference call on Tuesday, … The company’s quarterly earnings will be released the … live webcast of the earnings conference call can be … investor.myriad.com. About Myriad Genetics
Myriad Genetics is a leading genetic …
-
Myriad Genetics Reports Strong Fourth Quarter and Full-Year 2023 Financial Results; Fourth Quarter Revenue of $197 Million and Full-Year Revenue of $753 Million Each Grew 11% Year-Over-Year; Delivered GAAP EPS of $(0.36) and Adjusted EPS of $0.04 in…
27 Feb 2024 21:05 GMT
… Myriad Genetics is growing, projecting to be profitable on an adjusted earnings … .myriad.com. About Myriad Genetics
Myriad Genetics is a leading genetic … , SneakPeek
Pharmacogenomics – GeneSight
MYRIAD GENETICS, INC.
AND SUBSIDIARIES
Consolidated Statements …
-
Myriad Genetics, Inc. (NASDAQ:MYGN) Q4 2023 Earnings Call Transcript
28 Feb 2024 15:41 GMT
Myriad Genetics, Inc. (NASDAQ:MYGN) Q4 2023 Earnings Call Transcript February 27, 2024
Myriad Genetics, … Inc. beats earnings expectations. Reported EPS … here for my first earnings call with Myriad Genetics. Like Sam, I …
-
Myriad Genetics Inc. Q4 Earnings Summary
27 Feb 2024 21:43 GMT
Below are the earnings highlights for Myriad Genetics Inc. (MYGN):
Earnings: -$31.2 million in … year.
Excluding items, Myriad Genetics Inc. reported adjusted earnings of $3.5 million …